MALAT1 and nonpapillary renal cell carcinoma: Additionally, silencing of MALAT1 in ccRCC cells could enhance the sensitivity to sunitinib by modulating miR-362-3p/Ras-GTPase-activating SH3-domain-binding protein 1 (G3BP1) axis [37].